Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT00804583

Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease

Sponsor: University of North Carolina, Chapel Hill

View on ClinicalTrials.gov

Summary

This study examines "modifier genes" that may play a role in the development of CF liver disease. Modifier genes are genes, other than the CF gene (CFTR), which may directly or indirectly have an affect on how the body responds to the conditions that develop as the result of the defective CFTR gene. Scientists have wondered why some patients with CF develop CF liver disease and why some patients with CF do not. To better understand the problem, this study was designed to examine the genetic makeup of CF patients who are considered to have severe liver disease to see if they can identify any modifier genes. Researchers will study blood samples, pulmonary function tests, and other medical information in hopes that a connection can be made between genetic make-up and how severe the liver disease is. The identification of modifier genes that influence disease severity may ultimately lead to a better understanding of CF liver disease, and may be useful in the development of new treatments.

Official title: Genetic Modifiers of CF Liver Disease

Key Details

Gender

All

Age Range

2 Years - Any

Study Type

OBSERVATIONAL

Enrollment

154

Start Date

2004-03

Completion Date

2027-07

Last Updated

2025-09-23

Healthy Volunteers

No

Locations (1)

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States